Advanced search
Publication Cover
Leukemia & Lymphoma Volume 45, 2004 - Issue 4
Submit an article Journal homepage
74
Views
13
CrossRef citations to date
0
Altmetric
Original Article

Enhanced Cytotoxicity of Rituximab Following Genetic and Biochemical Disruption of Glycosylphosphatidylinositol Anchored Proteins

Nagaprasad Nagajothi Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD, 21231-1000, USACorrespondence[email protected]
,
William H Matsui Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD, 21231-1000, USA
,
Galina L Mukhina Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD, 21231-1000, USA
&
Robert A Brodsky Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD, 21231-1000, USA
Pages 795-800 | Received 10 Sep 2003, Published online: 03 Aug 2009

Citations (13)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Raymond I. Cruz, Francisco J. Hernandez-Ilizaliturri, Scott Olejniczak, George Deeb, Joy Knight, Paul Wallace, Beth L. Thurberg, William Kennedy & Myron S. Czuczman. (2007) CD52 over-expression affects rituximab-associated complement-mediated cytotoxicity but not antibody-dependent cellular cytotoxicity: Preclinical evidence that targeting CD52 with alemtuzumab may reverse acquired resistance to rituximab in non-Hodgkin lymphoma. Leukemia & Lymphoma 48:12, pages 2424-2436.
Read now

Articles from other publishers (12)

Linn Reinholdt, Maria Bach Laursen, Alexander Schmitz, Julie Støve Bødker, Lasse Hjort Jakobsen, Martin Bøgsted, Hans Erik Johnsen & Karen Dybkær. (2016) The CXCR4 antagonist plerixafor enhances the effect of rituximab in diffuse large B-cell lymphoma cell lines. Biomarker Research 4:1.
Crossref
Ruben Pio, Leticia Corrales & John D. Lambris. 2014. Tumor Microenvironment and Cellular Stress. Tumor Microenvironment and Cellular Stress 229 262 .
Radha Raghupathy & Olga Derman. (2012) Response of Paroxysmal Nocturnal Hemoglobinuria Clone with Aplastic Anemia to Rituximab. Case Reports in Hematology 2012, pages 1-5.
Crossref
Rong Hu, Galina L. Mukhina, Soo Hee Lee, Richard J. Jones, Paul T. Englund, Patrick Brown, Saul J. Sharkis, J. Thomas Buckley & Robert A. Brodsky. (2009) Silencing of genes required for glycosylphosphatidylinositol anchor biosynthesis in Burkitt lymphoma. Experimental Hematology 37:4, pages 423-434.e2.
Crossref
William Matsui, Qiuju Wang, James P. Barber, Sarah Brennan, B. Douglas Smith, Ivan Borrello, Ian McNiece, Lan Lin, Richard F. Ambinder, Craig Peacock, D. Neil Watkins, Carol Ann Huff & Richard J. Jones. (2008) Clonogenic Multiple Myeloma Progenitors, Stem Cell Properties, and Drug Resistance. Cancer Research 68:1, pages 190-197.
Crossref
Briuglia Silvana, La Mazza Antonella, Piraino Basilia, Domenico Trombetta, Antonella Saija & Carmelo Salpietro. (2007) Rituximab for the treatment of post-bone marrow transplantation refractory hemolytic anemia in a child with Omenn's syndrome. Pediatric Transplantation 11:5, pages 552-556.
Crossref
Deborah A. Thomas, Farhad Ravandi & Hagop Kantarjian. (2006) Monoclonal Antibody Therapy for Hairy Cell Leukemia. Hematology/Oncology Clinics of North America 20:5, pages 1125-1136.
Crossref
J D Isaacs, G S Jackson & D M Altmann. (2006) The role of the cellular prion protein in the immune system. Clinical and Experimental Immunology 146:1, pages 1-8.
Crossref
James M.G. Larkin, Peter J. Norsworthy, Roger P. A'Hern, Tim G. Eisen, Martin E. Gore & Colin D. Porter. (2006) Anti-αGal-dependent complement-mediated cytotoxicity in metastatic melanoma. Melanoma Research 16:2, pages 157-163.
Crossref
Yasuhito Terui, Takuma Sakurai, Yuko Mishima, Yuji Mishima, Natsuhiko Sugimura, Chino Sasaoka, Kiyotsugu Kojima, Masahiro Yokoyama, Nobuyuki Mizunuma, Shunji Takahashi, Yoshinori Ito & Kiyohiko Hatake. (2006) Blockade of bulky lymphoma-associated CD55 expression by RNA interference overcomes resistance to complement-dependent cytotoxicity with rituximab. Cancer Science 97:1, pages 72-79.
Crossref
Andrew Zelenetz. 2006. The Lymphomas. The Lymphomas 249 277 .
John P. Leonard, Morton Coleman, Jamie Ketas, Michelle Ashe, Jennifer M. Fiore, Richard R. Furman, Ruben Niesvizky, Tsiporah Shore, Amy Chadburn, Heather Horne, Jacqueline Kovacs, Cliff L. Ding, William A. Wegener, Ivan D. Horak & David M. Goldenberg. (2005) Combination Antibody Therapy With Epratuzumab and Rituximab in Relapsed or Refractory Non-Hodgkin's Lymphoma. Journal of Clinical Oncology 23:22, pages 5044-5051.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.